MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares
Globe Newswire•05/11/2026•16:05 ET
0
Key Highlights
- ➤MediWound (MDWD) closed a $17.25 million bought deal offering
- ➤Offering comprised 1,380,000 ordinary shares priced at $12.50 each
- ➤Underwriter fully exercised its option for 180,000 additional shares
- ➤Net proceeds will fund working capital and general corporate purposes
MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares
YAVNE, Israel, November 5, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the closing of its previously announced underwritten public offering of 1,380,000 ordinary shares, including 180,000 ordinary shares issued pursuant to the full exercise of the underwriter’s option to purchase additional ordinary shares, at a public offering price of $12.50 per ordinary share.
Get started
Create a free account to read the full story.